Search Results - "V. V. Omelyanovskiy"

Refine Results
  1. 1

    Clinical-economic evaluation of distance education and blood glucose level monitoring in adults with diabetes mellitus by Omelyanovskiy, V. V., Fediaeva, V. K.

    “…Background. Health Technology Assessment (HTA) in the Russian Federation has been performed for drugs, not for other medical technologies, which leads to…”
    Get full text
    Journal Article
  2. 2

    Peculiarities of real-world data application for health technology assessment in Asian countries by Kondratyeva, B. B., Gorkavenko, F. V., Omelyanovskiy, V. V.

    Published in Farmakoèkonomika (Moskva. Online) (01-02-2024)
    “…The article is devoted to the study of regulatory approaches to the sphere of real-world data (RWD) and real world evidence (RWE) in the countries of the…”
    Get full text
    Journal Article
  3. 3

    Review of international practice of health care provider network planning by Omelyanovskiy, V. V., Lukyantseva, D. V., Sisigina, N. N.

    Published in Farmakoèkonomika (Moskva. Online) (09-10-2022)
    “…Objevtive : to identify and systematize the main approaches to planning health care provider network used in foreign countries. Material and methods …”
    Get full text
    Journal Article
  4. 4

    Approaches to determining the cost of laboratory tests by Khayrullin, I. I., Omelyanovskiy, V. V., Gostishchev, R. V., Sukhorukikh, O. A., Kovaleva, S. A., Gorodetsky, B. G.

    Published in Farmakoèkonomika (Moskva. Online) (03-08-2024)
    “…Background . Determining the cost of laboratory tests is a significant factor in the context of economic analysis and management of clinical diagnostic…”
    Get full text
    Journal Article
  5. 5

    Analysis of tariff agreements of the constituent entities of the Russian Federation: form and completeness of data presentation by Fedyaev, D. V., Nikitin, F. S., Artamonova, T. N., Kovaleva, S. A., Omelyanovskiy, V. V.

    Published in Farmakoèkonomika (Moskva. Online) (09-11-2023)
    “…Background. Each constituent entity of the Russian Federation (RF) on the basis of the territorial programme of state guarantees of free medical care for…”
    Get full text
    Journal Article
  6. 6

    Improving the efficiency of the medicine provision system for patients with malignant neoplasms by Agafonova, Yu. A., Fedyaev, D. V., Snegovoy, A. V., Omelyanovskiy, V. V.

    Published in Farmakoèkonomika (Moskva. Online) (27-07-2022)
    “…Background . One of the priorities of health care is the balance between the financial resources and the availability of effective medical care. The current…”
    Get full text
    Journal Article
  7. 7

    IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? by V. V. Omelyanovskiy

    Published in Farmakoèkonomika (Moskva. Online) (01-05-2015)
    “…the analysis of foreign pricing and drug supply public funding systems (or a so-called drug reimbursement) shows a substantial variety and presence of national…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Principles of medical care standards development based on clinical guidelines by Ledovskikh, Yu. A., Tishkina, S. N., Pirova, G. I., Semakova, E. V., Omelyanovskiy, V. V.

    Published in Farmakoèkonomika (Moskva. Online) (21-04-2023)
    “…Objective: to review legislative and regulatory legal acts and other documents and consider the changing requirements for the development of medical care…”
    Get full text
    Journal Article
  10. 10

    Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making by Lemeshko, V. A., Musina, N. Z., Omelyanovskiy, V. V.

    Published in Farmakoèkonomika (Moskva. Online) (18-11-2020)
    “…Aim. Development of a tool for the evaluation of the therapeutic value of anticancer drugs based on multi-criteria analysis of decision making. Materials and…”
    Get full text
    Journal Article
  11. 11

    Unified system and classification of indicators for integral assessment of the performance and effectiveness of medical care organization at the regional level in the Russian Federation by Omelyanovskiy, V. V., Mikhailov, I. А., Lukyantseva, D. V., Samsonova, Е. S., Lebedenko, G. G.

    Published in Farmakoèkonomika (Moskva. Online) (20-01-2023)
    “…Objective: development of a unified system and classification of indicators for an integral assessment of performance and effectiveness of the organization of…”
    Get full text
    Journal Article
  12. 12

    Methodological approach to the formation of the list of high-tech medical care types by Zheleznyakova, I. A., Volkova, O. A., Fedyaev, D. V., Zuev, A. V., Plakhotnik, O. S., Trifonova, G. V., Zueva, Yu. S., Alexandrov, I. A., Omelyanovskiy, V. V.

    Published in Farmakoèkonomika (Moskva. Online) (20-07-2023)
    “…Background . The implementation of individual methods of high-tech medical care (HTMC) with methods of specialized medical care within the framework of a…”
    Get full text
    Journal Article
  13. 13

    Real-world data: principles of use in decision making and in health technology assessment by Omelyanovskiy, V. V., Gorkavenko, F. V., Ignatyeva, N. V., Mukhortova, P. A., Ryzhova, O. R., Teptsova, T. S., Kingshott, A. A., Kondratyeva, B. B.

    Published in Farmakoèkonomika (Moskva. Online) (19-07-2023)
    “…The use of real-world data (RWD) and real-world evidence (RWE) in process of improving public health, their assessment, and use in decision making is a…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Clinical approbation today: analysis of current problems and solutions by Omelyanovskiy, V. V., Lukyantseva, D. V., Alekseeva, T. I., Voropaeva, Yu. V., Tomilina, T. A., Teryan, R. A., Gadzhieva, A. O.

    Published in Farmakoèkonomika (Moskva. Online) (21-04-2023)
    “…Objective: description of the current problems concerning the development and conducting of a protocol of clinical approbation (CA) of methods of prevention,…”
    Get full text
    Journal Article
  16. 16

    Drug provision and health technology assessment in France by Omelyanovskiy, V. V., Nikitina, A. V., Lemeshko, V. A., Khachatryan, G. R.

    Published in Farmakoèkonomika (Moskva. Online) (24-04-2020)
    “…The article presents the description of structural, organizational and methodological issues of health technology assessment (HTA) of French drugs as well as…”
    Get full text
    Journal Article
  17. 17

    Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy by Lemeshko, V. A., Matrenin, K. I., Omelyanovskiy, V. V., Vasilyeva, Yu. V., Khachatryan, G. R., Kolganov, L. A.

    Published in Farmakoèkonomika (Moskva. Online) (29-04-2021)
    “…Objective : the development and approbation of the method for comparative analysis of the lists of medicines in different countries and systems of healthcare…”
    Get full text
    Journal Article
  18. 18

    The health technology assessment system in Australia by Omelyanovskiy, V. V., Saybel, E. S., Bezdenezhnykh, T. P., Khachatryan, G. R.

    Published in Farmakoèkonomika (Moskva. Online) (18-02-2020)
    “…In Australia, the federal government is in charge of providing the health care to patients. The government agencies determine the list of reimbursable…”
    Get full text
    Journal Article
  19. 19

    Evolution of healthcare provider payment mechanisms by Omelyanovskiy, V. V., Sisigina, N. N., Fedyaeva, V. K., Musina, N. Z.

    Published in Farmakoèkonomika (Moskva. Online) (18-02-2020)
    “…Methods of payment to care providers constitute an essential part of the healthcare financing system; these mechanisms determine the motivation of service…”
    Get full text
    Journal Article
  20. 20

    Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation by Bessonova, T. O., Gorkavenko, F. V., Shchurov, D. G., Seryapina, Yu. V., Chetverikova, O. R., Omelyanovskiy, V. V., Krivolapov, S. N., Neminushchiy, N. M., Kalemberg, A. A.

    Published in Farmakoèkonomika (Moskva. Online) (14-04-2022)
    “…Objective : to evaluate cost-effectiveness and budget impact of using single and dual chamber implantable cardioverter-defibrillators (ICD) adjunctive to the…”
    Get full text
    Journal Article